A 45-year-old male, Asian Indian physician, while making rounds in the hospital, developed crushing substernal chest pain. At the emergency department, an EKG revealed 2- to 3-mm ST elevation in V1-V6 ...

BMS and J&J's Librexia AF study is also comparing milvexian to Eliquis to see if it can prevent stroke and other clotting ...

Non-ST elevation myocardial infarction (NSTEMI) represents a significant clinical entity within the spectrum of acute ...

An acute coronary syndrome occurs when atherosclerotic coronary plaque becomes unstable, leading to a series of events eventually resulting in partial or total thrombotic occlusion of a coronary ...

Disruption of the fibrous cap on vulnerable atherosclerotic coronary plaques leads to exposure of the thrombogenic lipid core to the bloodstream, and is responsible for two-thirds of all coronary ...

According to a recent study, patients age 90 and older who came to the emergency room with acute coronary syndromes were less likely than younger patients to receive recommended treatments -- but for ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025" report to their offering.

Key points A 56-year-old woman presented to the emergency department with a 2-day history of central chest pain and dyspnea. Her medical history included having had a myocardial infarction (MI) with n ...

Acute coronary syndrome (ACS) in younger patients presents distinctive epidemiological and clinical patterns when compared with older cohorts. Although traditionally viewed as a disease of older ...

Heart attacks kill more seniors by far than any other disease. “Atherosclerosis” is the cause; it means “artery hardening.” First, fatty deposits, or “atheromas,” appear in the artery lining. This ...

A study published in the Journal of the American Heart Association (J Am Heart Assoc) by Zhang et al. (2025) highlights how ...

Milvexian’s failure in acute coronary syndrome dampens the outlook for other anticoagulants like it and is the latest in a ...